Prescription Required
Inclusive of all taxes
In Abdominal pain Mefatin Spas 10 mg/250 mg/10 mg Tablet gives relief from abdominal pain and works best if they are used when the first signs of pain occur. It slows the natural movements of the gut and relaxes the muscles in the stomach and intestines. By doing this, it relieves stomach cramps, pain, bloating and discomfort. Mefatin Spas 10 mg/250 mg/10 mg Tablet also reduces acidity and gives relief from heartburn.
It is unsafe to consume alcohol with Mefatin Spas 10 mg/250 mg/10 mg Tablet.
Mefatin Spas 10 mg/250 mg/10 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Mefatin Spas 10 mg/250 mg/10 mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Mefatin Spas 10 mg/250 mg/10 mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Mefatin Spas 10 mg/250 mg/10 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mefatin Spas 10 mg/250 mg/10 mg Tablet may be needed. Please consult your doctor.
Mefatin Spas 10 mg/250 mg/10 mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Mefatin Spas 10 mg/250 mg/10 mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Mefatin Spas 10 mg/250 mg/10 mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
| QTY | Stock Status | Brand Name | Generic Name | Strength | Form | Size | MRP | Discount | Net Cost | MFR | Type | Add Cart |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No substitutes found. | ||||||||||||